Dr Matthew Boyles

Post Nominals	BSc (Hons), PhD
Biography	Dr Matthew Boyles is a lecturer of Biomedical Sciences within the School of Applied Sciences at Edinburgh Napier University (ENU), Scotland, UK. Matthew attained a BSc (Hons) in Biomedical Science in 2007 from ENU, and his PhD studying the toxicity and potential pathogenicity of high-performance engineered multi-walled carbon nanotubes in 2011, also from ENU. Since, Matthew worked for four years at the BioNano Interactions, Human Immunity, Molecular Immunology research group in Salzburg University, Austria, as a Marie Curie Fellow within the EU FP7 ITN NanoTOES, and as a post-doctoral researcher on the EU FP7 consortium Nanovalid. This was followed by a two-year post-doctoral position at Heriot-Watt University, Edinburgh, Scotland, working on an industry funded project investigating health implications pertaining to in vitro exposure to various materials of the man-made fibre industry. Directly before joining ENU as a lecturer, Matthew worked as a consultant at the Institute of Occupational Medicine in Scotland for over six years, first as Senior Toxicologist and then as Research Team Lead of the Hazardous Materials Group. Matthew’s research interests focus on the human hazard assessment of nanomaterials and other advanced materials. This includes understanding the mechanisms of toxicity induced by these materials, as well as the development and optimisation of New Approach Methodologies (NAMs) to help improve the reliability and application of in vitro techniques; improved methodologies will enable industry and regulators to better cope with the increasing hazard assessment demands of new technologies, and will reduce the reliance on in vivo testing.

Post Nominals

BSc (Hons), PhD

Biography

Dr Matthew Boyles is a lecturer of Biomedical Sciences within the School of Applied Sciences at Edinburgh Napier University (ENU), Scotland, UK.
Matthew attained a BSc (Hons) in Biomedical Science in 2007 from ENU, and his PhD studying the toxicity and potential pathogenicity of high-performance engineered multi-walled carbon nanotubes in 2011, also from ENU.
Since, Matthew worked for four years at the BioNano Interactions, Human Immunity, Molecular Immunology research group in Salzburg University, Austria, as a Marie Curie Fellow within the EU FP7 ITN NanoTOES, and as a post-doctoral researcher on the EU FP7 consortium Nanovalid. This was followed by a two-year post-doctoral position at Heriot-Watt University, Edinburgh, Scotland, working on an industry funded project investigating health implications pertaining to in vitro exposure to various materials of the man-made fibre industry. Directly before joining ENU as a lecturer, Matthew worked as a consultant at the Institute of Occupational Medicine in Scotland for over six years, first as Senior Toxicologist and then as Research Team Lead of the Hazardous Materials Group.
Matthew’s research interests focus on the human hazard assessment of nanomaterials and other advanced materials. This includes understanding the mechanisms of toxicity induced by these materials, as well as the development and optimisation of New Approach Methodologies (NAMs) to help improve the reliability and application of in vitro techniques; improved methodologies will enable industry and regulators to better cope with the increasing hazard assessment demands of new technologies, and will reduce the reliance on in vivo testing.